Platinum Biolabs Expands Product Line Into Liquid Sprays

[HOUSTON, TX, September 14, 2026] -- Platinum Biolabs is expanding its research-use product line into liquid spray formats, adding NAD+, Semax, and Selank as part of the company's continued focus on research, product development, and innovation within the research-use compound market.

Based in Houston, Texas, Platinum Biolabs focuses on research-use peptides and compounds, with product quality, transparency, and clear documentation remaining central to its approach. The expansion into liquid sprays represents another step in the company's ongoing effort to develop its product range while maintaining a straightforward research-use positioning.

Adding new formats gives the company an opportunity to broaden its research-use offering while responding to the evolving needs of researchers seeking different product formats. The introduction of NAD+, Semax, and Selank into the liquid spray line reflects Platinum Biolabs' interest in product innovation and continued development.

The expansion also complements the company's existing focus on quality information. Platinum Biolabs emphasizes Certificates of Analysis (COAs), purity information, and batch-level testing as important components of its approach to research-use products. COAs are available through the company's COA request page, providing access to relevant product documentation.

NAD+ is also supported by specific product information supplied by the company. NAD+ has a reported purity of 99.56% and passed the NAD+ endotoxin test. The figure and testing result are presented as supplied by Platinum Biolabs and are intended to provide factual product information within the company's research-use context.

"Expanding into liquid sprays gives us another way to develop our research-use product line while keeping quality and transparency at the center," said Sean Varghese, Owner of Platinum Biolabs. "Our goal is to continue introducing new formats while maintaining clear product information, batch testing, and access to available COAs."

The new liquid spray offering includes NAD+, Semax, and Selank, giving the company an additional format alongside its broader research-use product portfolio. The expansion is positioned as a product-development initiative rather than a change in the company's research-use focus.

For Platinum Biolabs, innovation is closely connected to how products are presented and documented. Developing new formats is one part of the company's broader strategy, while maintaining transparent product information provides continuity across its growing line.

The company also continues to emphasize documented testing for selected products. In addition to the supplied NAD+ information, AOD-9604 has a reported purity of 99.65% and passed the endotoxin test. These figures are presented as client-supplied product data and are not being used to make medical, therapeutic, or efficacy claims.

Transparency remains particularly important as a product line expands. Researchers reviewing research-use compounds can access available COA information through Platinum Biolabs' COA request process, while the company continues to place emphasis on communicating product details in a clear and factual manner.

The move into liquid sprays follows Platinum Biolabs' broader efforts to expand its research-use offering. Rather than focusing solely on increasing the number of products -- the company is also developing additional formats that add variety to its portfolio.

This approach reflects a balance between research, innovation, and product quality. New formats can broaden the company's offering, while its established focus on COAs, batch testing, purity information, and transparency provides a consistent foundation for communicating product details.

As Platinum Biolabs continues to develop its product line from Houston, Texas, the company remains focused on research-use compounds and on providing clear information around the products it offers. The addition of liquid sprays featuring NAD+, Semax, and Selank marks another development in that ongoing expansion.

The company's priorities remain straightforward: support research-use product development, maintain attention to quality and documentation, and provide researchers with transparent information they can review.

For more information about Platinum Biolabs and its research-use product offering, visit platinumbiolabs.com.

About Platinum Biolabs

Platinum Biolabs is a research-use compound company with products made in Houston, Texas. Founded in 2025, the company focuses on research-use peptides and compounds, with an emphasis on product purity, batch testing, COAs, transparency, fulfillment, and continued product development.

Media Contact

Platinum Biolabs

Website: platinumbiolabs.com

COMTEX_492605023/2891/2026-09-14T08:08:16

You May Also Be Interested In

• Winthrop Wealth Named to the 2026 Inc. 5000
• SPRAYWAY AND NASCAR DRIVER JEB BURTON SHARE RACE-INSPIRED TIPS FOR FALL DRIVING VISIBILITY
• AROMATICA, the Only K-Hair Care Brand at the New Target Beauty Studio, Backed by 20 Years of Scalp Care Expertise